Junshi Biosciences Announces NMPA Accepted supplemental New Drug Application for Toripalimab in Combination with Chemotherapy as First-Line Treatment of Advanced NSCLC

6th indication for toripalimab submitted in China SHANGHAI, China, Dec. 10, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the National Medical Products Administration (the “NMPA”) has accepted the company’s supplemental New Drug Application (“sNDA”) […]

Continue Reading

Rapist of 12 students can receive castration punishment: ministry

The Women’s Empowerment and Child Protection Ministry stated that the perpetrator of rape against 12 female students in Bandung could receive additional sentence of castration in accordance with the applicable law. “We support the ongoing judicial process and encourage the application of strict and maximum penalties for defendants, who committed heinous acts against children seeking […]

Continue Reading